Polycomb group proteins: New targets of anti-cancer therapy

被引：5
|
作者：
Kang, Mo K. [1 ]
机构：
[1] Univ Calif Los Angeles, Sch Dent, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA
来源：
CELL CYCLE | 2010年 / 9卷 / 14期
关键词：
SELF-RENEWAL; STEM-CELLS; PROLIFERATION; INHIBITORS;
D O I：
10.4161/cc.9.14.12322
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2704 / 2704
页数：1
相关论文
共 50 条
  • [31] Diverse gene regulatory mechanisms mediated by Polycomb group proteins during neural development
    Tsuboi, Masafumi
    Hirabayashi, Yusuke
    Gotoh, Yukiko
    CURRENT OPINION IN NEUROBIOLOGY, 2019, 59 : 164 - 173
  • [32] Dependence receptors: new targets for cancer therapy
    Brisset, Morgan
    Grandin, Melodie
    Bernet, Agnes
    Mehlen, Patrick
    Hollande, Frederic
    EMBO MOLECULAR MEDICINE, 2021, 13 (11)
  • [33] Polycomb group proteins in hematopoietic stem cell aging and malignancies
    Klauke, Karin
    de Haan, Gerald
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (01) : 11 - 23
  • [34] Expression profile of polycomb group proteins in odontogenic keratocyst and ameloblastoma
    Lapthanasupkul, Puangwan
    Juengsomjit, Rachai
    Poomsawat, Sopee
    Arayapisit, Tawepong
    ACTA HISTOCHEMICA, 2018, 120 (03) : 215 - 220
  • [35] Targeting de novo lipogenesis as a novel approach in anti-cancer therapy
    Stoiber, Katharina
    Naglo, Olga
    Pernpeintner, Carla
    Zhang, Siwei
    Koeberle, Andreas
    Ulrich, Melanie
    Werz, Oliver
    Mueller, Rolf
    Zahler, Stefan
    Lohmueller, Theobald
    Feldmann, Jochen
    Braig, Simone
    BRITISH JOURNAL OF CANCER, 2018, 118 (01) : 43 - 51
  • [36] Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance
    Zanoni, Michele
    Bravaccini, Sara
    Fabbri, Francesco
    Arienti, Chiara
    FRONTIERS IN MEDICINE, 2022, 9
  • [37] Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
    Di Francia, Raffaele
    De Monaco, Angela
    Saggese, Mariangela
    Iaccarino, Giancarla
    Crisci, Stefania
    Frigeri, Ferdinando
    De Filippi, Rosaria
    Berretta, Massimiliano
    Pinto, Antonio
    CURRENT CANCER DRUG TARGETS, 2018, 18 (05) : 499 - 511
  • [38] Targeting de novo lipogenesis as a novel approach in anti-cancer therapy
    Katharina Stoiber
    Olga Nagło
    Carla Pernpeintner
    Siwei Zhang
    Andreas Koeberle
    Melanie Ulrich
    Oliver Werz
    Rolf Müller
    Stefan Zahler
    Theobald Lohmüller
    Jochen Feldmann
    Simone Braig
    British Journal of Cancer, 2018, 118 : 43 - 51
  • [39] Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy
    Wu, Manling
    Wang, Min
    Jia, Haoyuan
    Wu, Peipei
    DRUG DELIVERY, 2022, 29 (01) : 2513 - 2538
  • [40] Proteases as Anti-Cancer Targets - Molecular and Biological Basis for Development of Inhibitor-Like Drugs Against Cancer
    Bialas, A.
    Kafarski, P.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (07) : 728 - 762
12345